Black Diamond Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.5M | 1.9M | 2.81 |
| 2023-09-30 | $5.6M | 2.0M | 2.87 |
| 2023-06-30 | $7.5M | 1.5M | 5.05 |
| 2023-03-31 | $1.4M | 758k | 1.89 |
| 2022-12-31 | $1.4M | 758k | 1.80 |
| 2022-06-30 | $1.6M | 665k | 2.46 |
| 2022-03-31 | $1.9M | 677k | 2.77 |
| 2021-09-30 | $9.3M | 1.1M | 8.46 |
| 2021-06-30 | $19M | 1.6M | 12.20 |
| 2021-03-31 | $46M | 1.9M | 24.26 |
| 2020-12-31 | $59M | 1.8M | 32.06 |
| 2020-09-30 | $49M | 1.6M | 30.23 |
| 2020-06-30 | $35M | 836k | 42.17 |
| 2020-03-31 | $16M | 633k | 24.95 |